Viewing Study NCT03886493


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2026-01-05 @ 6:18 PM
Study NCT ID: NCT03886493
Status: TERMINATED
Last Update Posted: 2021-10-15
First Post: 2019-03-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: